Johnson Matthey (JM) looks back at a legacy of 200+ years. Established in 1817, the London, England-based chemical company reported annual revenues of about €18 billion...
Biopharma companies are facing funding challenges in 2023 as interest rates rise and investors are becoming more risk adverse. There is hope on the horizon, say some...
17.05.2023
- New buzzwords such as polycrisis and permacrisis are increasingly circulating, highlighting that we have grown accustomed to facing multiple crises since the 2000s, including 9/11...
The market value of US vaccine maker Novavax is gaining momentum again on the back of promising data the company recently provided on its combined Covid and flu vaccine...
India-based start-up Ashaya focuses on increasing the value of waste and turns this waste into high-quality materials and products that are more recyclable.
German family-owned industrial gases producer Messer has announced plans to build a carbon dioxide recovery plant at an undisclosed location in Austria, leveraging in...
